Top Health News — ScienceDaily Top stories featured on ScienceDaily’s Health & Medicine, Mind & Brain, and Living Well sections.
- Ancient Chinese medicine could transform hair loss treatmenton June 7, 2026 at 8:19 am
A traditional Chinese medicinal root used for over a thousand years is attracting new scientific attention for its potential to combat hair loss. Studies suggest Polygonum multiflorum can block harmful hormones, activate hair-growth signals, protect follicles, and boost blood flow to the scalp. Researchers say the herb’s effects align remarkably well with both ancient descriptions and modern hair biology.
- Ozempic and similar weight-loss drugs linked to 30% lower breast cancer riskon June 6, 2026 at 1:28 pm
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer.
- The supplements older adults actually need and the ones they don’ton June 6, 2026 at 12:40 pm
Supplements are often marketed as shortcuts to better health, but for many older adults, the real issue is whether they have a specific deficiency. Vitamins like B12 and D can play an important role when levels are low, while protein may be one of the most overlooked nutrients for maintaining strength and independence. More isn’t always better, though—some supplements can cause harm or interact with medications.
- Scientists sound the alarm as dangerous amoebas spread globallyon June 6, 2026 at 11:35 am
Scientists warn that free-living amoebae may be an underappreciated public health threat, capable of causing deadly infections and shielding other dangerous microbes from water treatment. Climate change and aging infrastructure could help these resilient organisms spread more widely in the years ahead.
- AI-designed universal coronavirus vaccine passes first human trialon June 5, 2026 at 3:42 pm
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe and well tolerated. The vaccine generated immune responses against multiple coronaviruses, including SARS-CoV-2, SARS, and related bat viruses with pandemic potential. By targeting features shared across an entire virus family, it aims to provide protection even as viruses evolve.
- Scientists discover why ozempic may not work for some peopleon June 5, 2026 at 3:13 pm
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of “GLP-1 resistance.” In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications.
- The biggest collagen study yet reveals what actually workson June 5, 2026 at 5:13 am
A major review of nearly 8,000 participants found that collagen supplements can improve skin health and ease osteoarthritis symptoms, especially when taken consistently over longer periods. Researchers also found modest benefits for muscle and tendon health. But the results challenge claims that collagen enhances sports performance, as it showed little effect on recovery or post-workout soreness.
- A study of 8,300 older adults revealed a surprising salt habiton June 4, 2026 at 2:05 pm
A large study of older adults in Brazil found that adding extra salt at the table is still a common habit, especially among men. While too much salt is linked to serious health problems and faster cognitive decline, researchers discovered that women’s salt-shaking habits were tied more closely to lifestyle and diet.
- Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survivalon June 4, 2026 at 1:18 pm
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn’t be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%.
- Scientists discover the master clock that controls biological growth and developmenton June 4, 2026 at 9:36 am
A newly discovered genetic clock acts as the master timekeeper for development, orchestrating crucial bursts of gene activity throughout a worm’s growth. When the clock is disrupted, development stops, offering fresh clues about how growth-related disorders may arise.